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ABSTRACT 
Background: Cardiac rehabilitation (CR) is strongly associated with all-cause mortality 
reduction in patients with coronary artery disease (CAD). The impact of CR on 
pathological risk factors, such as impaired glucose tolerance (IGT), and functional 
recovery remains under debate. The aim of the present study is to determine whether CR 
has a positive effect on physical exercise improvement and on pathological risk factors in 
IGT and diabetic patients with CAD. 
Methods: One hundred and seventy-one consecutive patients participating in a 3-month CR 
from January 2014 to June 2015 were enrolled. The primary endpoint was defined as an 
improvement of peak workload and VO2-peak; glycated hemoglobin (HbA1c) reduction 
was considered as a secondary endpoint.  
Results: Euglycemic patients presented a significant improvement in peak workload 
compared to diabetic patients (from 5.75 ± 1.45 to 6.65 ± 1.84 METs, p = 0.018 vs. 4.8 ± 
0.8 to 4.9 ± 1.4 METs). VO2-peak improved in euglycemic patients (VO2-peak from 19.3 ± 
5.3 mL/min/kg to 22.5 ± 5.9, p = 0.003), while diabetic patients did not present  a  statistically 
significant trend (VO2-peak from 16.9 ± 4.4 mL/min/kg to 18.0 ± 3.8, p < 0.056). Diabetic 
patients have benefited more in terms of blood glucose control compared to IGT patients 
(HbA1c from 7.7 ± 1.0 to 7.4 ± 1.1 compared to 5.6 ± 0.4 to 5.9 ± 0.5, p = 0.02, 
respectively). 
Conclusions: A multidisciplinary CR program improves physical functional capacity in 
CAD setting, particularly in euglycemic patients. IGT patients as well as diabetic patients 
may benefit from a CR program, but long-term outcome needs to be clarified in larger 
studies. 
Key words: cardiac rehabilitation, coronary artery disease, diabetes mellitus, reduced 
glucose tolerance, cardiopulmonary test 
 
 
Introduction 
Cardiovascular disease and acute coronary syndrome (ACS) represent a major 
source of morbidity and mortality in Western countries [1]. Cardiac rehabilitation (CR) has 
been strongly associated with a reduction in all-cause mortality in patients with coronary 
artery disease (CAD), hospital readmissions, costs and improvement in exercise capacity, 
quality of life and psychological well-being [2–5]. Therefore, CR is currently a mainstay of 
post-acute care strategy and is recommended by international guidelines for stable CAD 
(Class I, Level A). A multi-factorial intervention including patient assessment, physical 
activity/diet/nutritional counselling, exercise training, risk factor control, patient education, 
psychosocial management, and vocational advice are also recommended for patients with ST-
elevation acute myocardial infarction (Class I, Level B), and non ST-elevation myocardial 
infarction (Class IIa, Level A) [6, 7]. Exercise capacity, measured by VO2-peak, is an 
independent predictor of all-cause and cardiovascular mortality in patients with CAD [8, 
9]. Diabetic patients are known to be at higher risk for CAD, with a worse prognosis after a 
myocardial infarction compared to non-diabetic patients [10, 11]. Previous studies have 
shown that CR is less effective in these patients, probably due to impaired glycemic control 
[12]. Less is known about the value of impaired glucose tolerance (IGT) as a predictor of 
cardiovascular events in the long-term, however this condition seems to be associated with 
lower functional recovery [13, 14]. Recently, a positive association between IGT and left 
ventricular diastolic dysfunction was found in middle-age adults without left ventricular 
systolic impairment or valvular disease, even after correction for confounding factors [15]. 
The cardiopulmonary exercise testing (CPET) is commonly performed in patients with CAD 
to identify post-infarct residual ischemia and to monitor the progress of CR [16, 17]. The aim 
of the present study is to determine whether CR has a positive effect on exercise capacity 
and risk factor control in IGT and diabetic patients with CAD.  
 
Methods 
One hundred and seventy-one consecutive patients referred to Cardiocentro Ticino 
(Lugano, Switzerland) for CR, from January 2014 to June 2015, were enrolled in the study. 
Patients with severe renal failure (as defined by RIFLE classification — Risk, Injury, 
Failure, Loss of kidney function and End-stage renal disease based on creatinine clearance 
and urinary output) [18], severe peripheral arterial disease, severe respiratory disease or 
those simply unable to perform exercise training were excluded. Diabetes was diagnosed 
by plasma fasting glucose > 126 mg/dL (i.e. > 7.0 mmol/L) or by glycated hemoglobin 
(HbA1c) > 6.5%. A tri-weekly 2-h session of a comprehensive multidisciplinary CR 
program began on hemodynamically stable patients and continued for three months. The CR 
team consisted of physiotherapists, psychologists, nutritionists and an experienced 
cardiologist in cardiovascular rehabilitation. Each session included one or more group-based 
therapies, such as education about cardiovascular risk factors, dietary suggestions, and 
physiotherapy as well as exercise and stress management. Exercise sessions of aerobic 
exercise lasting 30 min,    including a warm-up and a cool-down activity. The intensity of 
exercise was prescribed individually, based on a target heart rate < 85% of the theoretical 
threshold. Demographic information, anthropometric parameters, medical history, ACS type, 
cardiovascular risk factors, medications as well as laboratory values were collected at baseline 
and after completing the CR program (at least > 75% of sessions). A CPET was performed at 
baseline and at the end of the CR program and was supervised by an experienced cardiologist. 
This ergometric CPET was conducted with variable work loads of 10 to 25 Watts every 1 or 2 
min (incremental protocol), according to a patient’s individual functional autonomy. A 
measurement of patient cardiopulmonary function, such as maximal metabolic equivalents 
(METs), peak workload and maximal oxygen consumption (VO2-peak), were collected at 
baseline and at the end of the CR program.  
 
Statistical analysis 
Variables were expressed as means ± standard deviation or percentage as appropriate. 
Comparisons between groups were performed using the two-tailed Student t-test or χ2 test as 
appropriate. Correlation coefficients were determined by linear regression analysis and 
statistical significance was determined with the Fisher and Yates test. Multivariable analyses 
were performed by stepwise linear regression or by stepwise logistic regression as 
appropriate. A p-value < 0.05 was considered to be statistically significant. Statistical analysis 
was performed using the SPSS software (SPSS 22.0 Inc., Chicago IL, USA).  
 
Results 
Out of 171 patients enrolled in the study, 148 (86.5%) completed the CR program; 87 
(50.9%) patients presented ACS in the prior4 weeks and 108 (63.1%) underwent a 
percutaneous transluminal coronary angioplasty (PTCA). After 1 week, 23 (13.4%) patients 
dropped out the CR program and another 4 patients were excluded from the analysis because 
of attendance of less than 75% of the sessions (less than 28 f the 36 sessions). Out of 144 
patients who completed the CR program, 34 (23.6%) patients were already known to have 
diabetes; 3 (2.1%) patients were newly diagnosed. Patients with a plasma fasting glucose 
between 100 and 126 mg/dL (i.e. 5.56 mmol/L and 7.0 mmol/L), independent of their history, 
were classified as IGT patients; of these 47 (32.6%) were newly diagnosed. The baseline 
characteristics of the 171 patients, were divided in three groups according to their baseline 
fasting glucose and enrolled in the study and are summarized in Table 1.  
 
Effects on exercise capacity based on glucose control 
Exercise capacity pre- and post-CR expressed by CPET parameters is summarized in 
Table 2. All groups showed significant intra-group improvement (Fig. 1) considering 
workload peak and VO2-peak (except IGT patients). Euglycemic patients benefited the most 
in terms of exercise capacity improvement (5.7 ± 1.4 to 6.6 ± 1.8 METs, p = 0.018). IGT 
patients presented a lower functional capacity recovery when compared to euglycemic 
patients (5.9 ± 1.9 to 6.3 ± 1.8 METs, p = 0.413) as well as diabetic patients (4.8 ± 0.8 to 4.9 
± 1.4, p = 0.072).  
A significant improvement in VO2-peak after completing CR was found in 
euglycemic patients (VO2-peak from 19.3 ± 5.3 mL/min/kg to 22.5 ± 5.9 mL/min/kg, p = 
0.003) and also in this case, IGT patients showed less benefit compared to euglycemic 
patients (VO2-peak from 20.2 ± 6.4 mL/min/kg to 21.5 ± 7.0 mL/min/kg, p = 0.42). Diabetic 
patients presented only a positive trend in VO2-peak compared to IGT (VO2-peak 17.0 ± 3.8 
mL/min/kg vs. 18.1 ± 4.4 mL/min/kg, p = 0.056). IGT patients presented with the most 
significant benefit in terms of fasting glucose reduction, in the absence of hypoglycemic 
therapy, compared to diabetic patients (plasma fasting glucose 6.5 ± 0.5 mmol/L to 6.2 ± 
0.9 mmol/L vs. 8.1 ± 1.8 mmol/L to 8.2 ± 1.9 mmol/L, p = 0.002). Diabetic patients, on the 
other hand, showed a more significant reduction of HbA1c levels compared to IGT patients 
(HbA1c 7.7 ± 1.1% to 7.5 ± 1.2% vs. 5.6 ± 0.4% to 6.0 ± 0.5%, p = 0.002). Finally, a trend 
showing an inverse correlation was found between baseline fasting glucose levels and 
ΔVO2-peak (ΔVO2-peak = 6.419925–0.721243*fasting glucose, p = 0.11, Fig. 2).  
 
Discussion 
In this study, results of a comprehensive CR program for CAD patients from a single 
center experience are presented (Cardiocentro Ticino, Lugano, Switzerland). In the current 
population, 13.4% of patients quit the CR program after 1 week. This dropout rate is in line 
with the data previously reported in the literature [19]. In a big prospective study, including 
more than 25,000 patients with at least one vessel CAD, diabetic patients were more likely to 
leave the CR program (odds ratio [OR] 0.65, 95% confidence interval [CI] 0.59–0.72), and, 
despite being less referred, women experienced a greater relative mortality benefit compared 
to men [20].  
 
Effects of CR programs on cardiovascular risk factors 
Exercise capacity measured by VO2-peak represents a strong predictor of survival in 
patients with CAD and is positively related to improvement in terms of morbidity [21].  
High-intensity interval training protocols have been developed and have been shown 
to lead to a significant increase in functional capacity compared to moderate continuous 
training [22]. International Guidelines recommend CR programs including a multimodal 
behavioral intervention for all patients with established CAD [6, 7]. 
Exercise is associated with improvements of typical cardiovascular risk factor control 
such as obesity, diabetes mellitus and hypertension [23]. In the present population, a reduction 
in weight as well as in waist circumference in all patients was found, independent of glycemic 
status, although these results were not statistically significant as reported in other previous 
studies published [24]. Moreover, CR is associated with an increase of muscular mass; 
therefore, weight loss may not reflect by itself a reduction in cardiovascular risk. An increase 
in oxygen peak consumption or improvement in glycemic control thus represent more useful 
indicators.  
 Effects of CR programs based on glycemic status 
The combination of aerobic and resistance training has been shown to be highly 
effective in reducing cardiovascular risk factors in patients with type 2 diabetes mellitus and 
is currently recommended by the American College of Sports Medicine and American Heart 
Association [25, 26]. In the analyses, it was found that IGT patients presented a more 
significant reduction in plasma fasting glucose compared to diabetic patients. On the other 
hand, diabetic patients showed a more significant reduction of HbA1c levels, compared to 
IGT patients. Based on these results, it can be extrapolated that these patients could 
benefit, in terms of glycemic control, from a longer CR program.    
The role of CR as long-term therapy to reduce cardiovascular risk factors after ACS is 
well established. In a prospective study including 846 patients treated with aorto-coronary by-
pass, CR attendance was associated with a significant reduction of 10-year all-cause mortality 
and CR program completion was the most important indicator for survival [27]. However, no 
differences in mortality according to glycemic status were found.  
In in vitro studies, hyperglycemia has been shown to lead to oxidative stress and thus, 
indirectly, to increase myocyte apoptosis, both in chronic and in acute settings [28, 29]. In the 
DARE study, a prospective multicenter study, 64 patients with diabetes mellitus type 2 were 
enrolled in a CR program after ACS. Patients were randomized according to baseline diabetes 
therapy; patients with better glycemic control, as measured by fructosamine levels, the 
parameter of short-term glycemic control showed higher values of VO2-peak at the end of CR 
[19]. In another prospective study including 682 patients undergoing CR after ACS, diabetic 
subjects presented a lower functional capacity at baseline compared to non-diabetics. 
Nevertheless, diabetics patients presented a significant improvement, expressed in METs and 
exercise duration, similar to those achieved by non-diabetic patients [30]. These findings were 
confirmed in another study including heart failure patients [31]. In the current study, it was 
also found that patients with diabetes have a lower functional capacity at baseline, with an 
improvement in functional capacity, expressed in terms of both higher peak workload (METs) 
and VO2-peak values at the end of the CR program when compared to IGT patients. 
Euglycemic patients, on the contrary, significantly improved both these parameters compared 
to diabetic patients.  
Data from the Italian SurveY on carDiac rEhabilitation (ISYDE-2008) including 2281 
patients referred to CR showed that patients with diabetes had more comorbidities and 23% of 
them were not able to perform any physical performance testing at all. The authors concluded 
that this finding might have prognostic relevance. A bias in the study involving diabetic 
patients undergoing CR has thus to be considered, as these patients may have been directly 
excluded from enrollment in CR programs [32].  
In the present study, euglycemic patients benefited the most from the CR program. 
IGT patients, however, presented a significant improvement of glycemic control compared to 
diabetic patients in terms of plasma fasting glucose. Diabetic patients, on the other hand, 
showed a statistically significant reduction of HbA1c. Taken together, these data suggest that 
improvement in glycemic control during CR may contribute to optimize functional recovery 
expressed in terms of workload- and VO2-peak, independently from other factors. These 
improvements are probably due to CR itself, and were independent of underlying therapy for 
diabetes. Several studies, however, failed to demonstrate the effectiveness of CR in diabetic 
patients [33, 34], although, according to some other authors, CR should be effective for these 
patients as well [35]. However, the discrepancies in these studies may be related to the 
heterogeneity of patients considered. In the current study, it was found that fasting glucose at 
baseline inversely correlated with VO2-peak improvement and this finding is in line with 
previously published data [12, 36]. Poor glycemic control seems to have unfavorable effects 
on cardiomyocytes and muscular cells, promoting overproduction of reactive oxygen species, 
alterations of myocardial endo-plasmatic reticulum, dysfunction of calcium metabolism and 
impairment of mitochondria metabolism [29, 37–39]. On the other hand, good glycemic 
control during CR may improve the VO2-peak [17] and may play a key role for a better long-
term prognosis as well.  
 
Limitations of the study 
This retrospective analysis, as well as the lack of a control group represent a limitation 
of this study, it is also burdened by a small number of patients, all Caucasian. Larger 
prospective studies are needed to better clarify the role of CR in diabetic patients.  
 
Conclusions 
This single-center experience showed how a multidisciplinary CR program provides 
better outcomes in terms of exercise capacity for euglycemic patients compared to IGT and 
diabetics patients. These latter patients could benefit from a longer CR program, overall in 
terms of glycemic control, independent from hypoglycemic therapies. The efficacy of CR in 
diabetic patients needs to be clarified in larger and prospective studies. 
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Table 1. Main characteristics of cardiac rehabilitation (CR) patients according to glycemic 
status.  
 Euglycemic (glycemic < 5.6 
mmol/L) (n = 88) 
IGT (glycemic 5.6–
7.0 mmol/L) (n = 59) 
Diabetics (glycemic > 7.0 
mmol/L) (n = 24) 
Age 60,45 63,35 69,30 
Male 53 66 24 
Familial history of CHD 25 23 4 
Hypertension 32 42 20 
Dyslipidemia 36 40 11 
Diabetes 1 12 21 
Smoking 35 38 6 
Statin therapy 56 61 21 
ACEI 40 41 19 
Beta-blockers 59 68 17 
Acetylsalicylic acid 64 68 24 
Stable angina 28 20 9 
Unstable angina 3 2 0 
NSTEMI 18 4 4 
STEMI 25 22 9 
PTCA 55 40 13 
CABG (also previous) 23 12 12 
Waist > 88 or > 102 cm 31 33 17 
Weight > 60 or > 70 kg 50 66 23 
Glucose –0.16  0.46 (p = 0.25) –0.35  0.75 (p = 0.02) 0.52  1.40 (p < 0.05) 
HbA1c 0.40  0.97 (p = 0.67) 0.28  0.53 (p = 0.28) –0.29  1.20 (p = 0.02) 
Data are presented as mean ± standard deviation or percentage. ACEI — angiotensin converting enzyme 
inhibitor; CABG — coronary artery by-pass graft; CHD — chronic heart disease; HbA1c — glycated 
hemoglobin; NSTEMI — non-ST-segment elevation myocardial infarction; PTCA — percutaneous transluminal 
coronary angioplasty; STEMI — ST-segment elevation myocardial infarction 
 
Table 2. Cardiopulmonary test values pre- and post- cardiac rehabilitation (CR).  
 Euglycemic (< 5.6) 
(n = 63) 
IGT (5.6–
7.0) (n=66) 
Diabetics (> 7.0) 
(n = 19) 
P 
Watt pre-CR 128.5 ± 41.2 128.4 ± 40.0 104.7 ± 38.2 0.02 
Watt post-CR 137.4 ± 44.0 142.1 ± 46.1 116.1 ± 41.3 0.08 
METs pre-CR 5.7 ± 1.4 5.9 ± 1.9 4.8 ± 0.8 0.03 
METs post-CR 6.6 ± 1.8 6.3 ± 1.8 4.9 ± 1.4 0.01 
VO2-peak pre-CR 19.3 ± 5.3 20.1 ± 6.3 16.9 ± 3.8 0.07 
VO2-peak post-CR 22.5 ± 5.9 21.5 ± 7.0 18.0 ± 4.4 < 0.05 
VO2 threshold pre-CR 13.9 ± 4.2 14.7 ± 4.3 12.3 ± 2.5 0.11 
VO2 threshold post-CR 16.0 ± 4.6 16.3 ± 4.6 13.7 ± 3.9 0.05 
O2 beat pre-CR 12.3 ± 3.1 13.0 ± 3.5 11.6 ± 2.3 0.35 
O2 beat post-CR 13.1 ± 3.4 13.5 ± 3.7 11.9 ± 2.9 0.19 
Breathe reserve pre-CR 40.8 ± 15.9 38.1 ± 15.3 37.0 ± 13.5 0.33 
Breath reserve post-CR 37.9 ± 17.1 37.0 ± 14.9 33.4 ± 14.6 0.31 
Data are presented as mean ± standard deviation. Statistical significance is shown for euglycemic patients vs. 
diabetics. IGT — impaired glucose tolerance; METs — metabolic equivalents; VO2 — oxygen volume 
 
 
Figure 1. Peak workload and VO2-peak improvement; A. Peak workload comparison 
between euglycemic (blue bars), impaired glucose tolerance (IGT; yellow bars) and diabetic 
patients (grey bars); B. VO2-peak comparison between euglycemic (blue bars), IGT (yellow 
bars) and diabetic patients (gray bars).  
 
Figure 2. Linear regression, showing an inverse correlation between fasting glucose and 
VO2-peak improvement, suggesting that response to cardiac rehabilitation (CR) may be 
impaired by poor glycemic control. 


